Cleveland Clinic Contemporary Issues In Pituitary Disease 2024

Innovations and advances in the field of pituitary disease—including evaluation, diagnosis, treatment, and prevention—continue to occur at a rapid pace, challenging both specialists and generalists to stay abreast of the data and their implications for clinical practice. This one-day program will include didactic and case-based talks and panel discussions by some of the finest experts in this field.

Who Should Attend?

Endocrinologists, neurosurgeons, family medicine, internal medicine physicians, physician assistants, residents, fellows, nurses, nurse practitioners and other allied health professionals who treat and manage patients with pituitary disease.

Learning Objectives

After completing this educational activity, participants will be able to do the following:

• Critically review the diagnostic tests available to differentiate the various hypercortisol disorders, including Cushing syndrome.
• Debate the therapeutic issues regarding management of hypercortisol levels, especially in patients with Cushing syndrome.
• Describe the pathologic causes of growth hormone disorders, both excess and deficiencies, and summarize their impact on different age groups.
• Compare and contrast the efficacy and side effect profiles of pharmaceutical therapies for acromegaly, both FDA approved and in development.
• List the clinical signs and symptoms of acromegaly, especially for pediatric gigantism, and identity their different causes and potential treatment.
• Describe the surgical options for pituitary tumors, patient selection criteria, and potential outcomes.
• Select optimal methodology for monitoring and treating sodium imbalances associated with pituitary tumor resection.
• Identify the appropriate use of MRI technologies and systematic approaches to differentiating sellar masses on MRI images.